AAAAAA

   
Results: 1-14 |
Results: 14
Differential expression of Bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells
Authors: Josefsen, D Myklebust, JH Lomo, J Sioud, M Blomhoff, HK Smeland, EB
Citation: D. Josefsen et al., Differential expression of Bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells, STEM CELLS, 18(4), 2000, pp. 261-272
Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell non-Hodgkin's lymphoma
Authors: Stokke, T Galteland, E Holte, H Smedshammer, L Suo, ZH Smeland, EB Borresen-Dale, AL DeAngelis, P Steen, HB
Citation: T. Stokke et al., Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell non-Hodgkin's lymphoma, INT J CANC, 89(4), 2000, pp. 313-324
cAMP-mediated growth inhibition of lymphoid cells in G1: rapid down-regulation of cyclin D3 at the level of translation
Authors: Naderi, S Gutzkow, KB Christoffersen, J Smeland, EB Blomhoff, HK
Citation: S. Naderi et al., cAMP-mediated growth inhibition of lymphoid cells in G1: rapid down-regulation of cyclin D3 at the level of translation, EUR J IMMUN, 30(6), 2000, pp. 1757-1768
Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer
Authors: Fossa, A Siebert, R Aasheim, HC Maelandsmo, GM Berner, A Fossa, SD Paus, E Smeland, EB Gaudernack, G
Citation: A. Fossa et al., Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer, BR J CANC, 83(6), 2000, pp. 743-749
Protein kinase C-alpha isoform is involved in erythropoietin-induced erythroid differentiation of CD34(+) progenitor cells from human bone marrow
Authors: Myklebust, JH Smeland, EB Josefsen, D Sioud, M
Citation: Jh. Myklebust et al., Protein kinase C-alpha isoform is involved in erythropoietin-induced erythroid differentiation of CD34(+) progenitor cells from human bone marrow, BLOOD, 95(2), 2000, pp. 510-518
A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes
Authors: Aasheim, HC Munthe, E Funderud, S Smeland, EB Beiske, K Logtenberg, T
Citation: Hc. Aasheim et al., A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes, BLOOD, 95(1), 2000, pp. 221-230
Evaluation of lymphoid cell populations in cytology specimens using flow cytometry and polymerase chain reaction
Authors: Davidson, B Risberg, B Berner, A Smeland, EB Torlakovic, E
Citation: B. Davidson et al., Evaluation of lymphoid cell populations in cytology specimens using flow cytometry and polymerase chain reaction, DIAGN MOL P, 8(4), 1999, pp. 183-188
Fas ligand promotes cell survival of immature human bone marrow CD34(+)CD38(-) hematopoietic progenitor cells by suppressing apoptosis
Authors: Josefsen, D Myklebust, JH Lynch, DH Stokke, T Blomhoff, HK Smeland, EB
Citation: D. Josefsen et al., Fas ligand promotes cell survival of immature human bone marrow CD34(+)CD38(-) hematopoietic progenitor cells by suppressing apoptosis, EXP HEMATOL, 27(9), 1999, pp. 1451-1459
Retinoic acid induces apoptosis of human CD34(+) hematopoietic progenitor cells: Involvement of retinoic acid receptors and retinoid X receptors depends on lineage commitment of the hematopoietic progenitor cells
Authors: Josefsen, D Blomhoff, HK Lomo, J Blystad, AK Smeland, EB
Citation: D. Josefsen et al., Retinoic acid induces apoptosis of human CD34(+) hematopoietic progenitor cells: Involvement of retinoic acid receptors and retinoid X receptors depends on lineage commitment of the hematopoietic progenitor cells, EXP HEMATOL, 27(4), 1999, pp. 642-653
Prognostic value of lymphoma-specific S-phase fraction compared with that of other cell proliferation markers
Authors: Holte, H Suo, Z Smeland, EB Kvaloy, S Langholm, R Stokke, T
Citation: H. Holte et al., Prognostic value of lymphoma-specific S-phase fraction compared with that of other cell proliferation markers, ACTA ONCOL, 38(4), 1999, pp. 495-503
Activation of the cAMP signaling pathway increases apoptosis in human beta-precursor cells and is associated with downregulation of Mcl-1 expression
Authors: Myklebust, JH Josefsen, D Blomhoff, HK Levy, FO Naderi, S Reed, LC Smeland, EB
Citation: Jh. Myklebust et al., Activation of the cAMP signaling pathway increases apoptosis in human beta-precursor cells and is associated with downregulation of Mcl-1 expression, J CELL PHYS, 180(1), 1999, pp. 71-80
Lovastatin inhibits G1/S transition of normal human B-lymphocytes independent of apoptosis
Authors: Naderi, S Blomhoff, R Myklebust, J Smeland, EB Erikstein, B Norum, KR Blomhoff, HK
Citation: S. Naderi et al., Lovastatin inhibits G1/S transition of normal human B-lymphocytes independent of apoptosis, EXP CELL RE, 252(1), 1999, pp. 144-153
Proliferation and apoptosis in malignant and normal cells in B cell non-Hodgkin's lymphomas
Authors: Stokke, T Holte, H Smedshammer, L Smeland, EB Kaalhus, O Steen, HB
Citation: T. Stokke et al., Proliferation and apoptosis in malignant and normal cells in B cell non-Hodgkin's lymphomas, BR J CANC, 77(11), 1998, pp. 1832-1838
Tumour cell proliferation, but not apoptosis, predicts survival in B cell non-Hodgkin's lymphomas
Authors: Stokke, T Smeland, EB Kvaloy, S Holte, H
Citation: T. Stokke et al., Tumour cell proliferation, but not apoptosis, predicts survival in B cell non-Hodgkin's lymphomas, BR J CANC, 77(11), 1998, pp. 1839-1841
Risultati: 1-14 |